Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Forest Labs says it won proxy fight with Icahn
Yahoo/AP
Thursday, August 18, 2011 - 12:33pm
tags:
Carl Icahn, Forest Labs
Exclusive: Nestle, Danone early leaders to land $10 billion Wyeth baby formula business
Yahoo/Reuters
Thursday, August 18, 2011 - 12:31pm
tags:
Nestle, Danone SA, Wyeth, infant formula, Abbott Laboratories, Mead Johnson Nutrition
Gene-Drug Matchmaker May Find New Uses for Old Medicines, Researchers Say
Bloomberg
Thursday, August 18, 2011 - 12:30pm
tags:
genes
8 Defensive High-Yield Pharmaceuticals to Consider
Seeking Alpha
Thursday, August 18, 2011 - 12:29pm
tags:
Abbott Laboratories, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, JNJ, Novartis, Pfizer, Sanofi
Sun Pharma Gets U.S. Approval for Generic Finasteride, FDA Says
Bloomberg
Thursday, August 18, 2011 - 12:28pm
tags:
generics, FDA, Sun Pharma, finasteride, Propecia, Proscar
Amarin Gets Final Rejection on Key Drug Patent
TheStreet.com
Thursday, August 18, 2011 - 9:22am
tags:
patents, Amarin, AMR101
Forest Labs CFO Takes Aim at Icahn Board Nominees
WSJ Online
Thursday, August 18, 2011 - 9:13am
tags:
Carl Icahn, Forest Labs
Lipitor Generic Rights May Be Sold Should Ranbaxy’s Approval Come Too Late
Bloomberg
Thursday, August 18, 2011 - 9:11am
tags:
Ranbaxy, Pfizer, Lipitor, generics
Why Abbott Laboratories' Earnings Are Outstanding
Motley Fool
Wednesday, August 17, 2011 - 5:22pm
tags:
Abbott Laboratories, earnings
Pfizer says EU starts review of 2 cancer drugs
Yahoo/AP
Wednesday, August 17, 2011 - 5:20pm
tags:
Europe, Pfizer, crizotinib, Bosutinib, lung cancer, chronic myeloid leukemia
Navigating Cancer Vaccines' High-Risk/High-Reward Field
Seeking Alpha
Wednesday, August 17, 2011 - 12:09pm
tags:
cancer, vaccines, Dendreon, Provenge, ICT-107, ImmunoCellular, Amgen
Qiagen Partners with Pfizer
Yahoo/Zacks.com
Wednesday, August 17, 2011 - 12:05pm
tags:
Qiagen, Pfizer, non-small cell lung cancer
Roche, Daiichi Sankyo Win U.S. Approval on Drug to Treat Advanced Melanoma
Bloomberg
Wednesday, August 17, 2011 - 12:03pm
tags:
Zelboraf, Roche, melanoma, FDA, Daiichi Sankyo
Digital Pharma: Bayer reprimanded over social media use
InPharm
Wednesday, August 17, 2011 - 9:07am
tags:
Bayer, social media, twitter
Zogenix to seek FDA approval of chronic-pain drug
Marketwatch
Wednesday, August 17, 2011 - 9:03am
tags:
FDA, Zogenix, chronic pain, Zohydro
Perrigo Profit Up 44%, But Sales Miss
Yahoo/InvestorsBusinessDaily
Wednesday, August 17, 2011 - 9:02am
tags:
earnings, Perrigo Company
Is China preparing to challenge the U.S. for biotech supremacy?
Fierce Biotech
Wednesday, August 17, 2011 - 8:57am
tags:
China, biotech
Array Represents a Great Opportunity for Very Patient Investors
Seeking Alpha
Wednesday, August 17, 2011 - 8:54am
tags:
Array Biopharma
Viagra Ruling Gives Boost to Pfizer Salesforce
FINS/WSJ Online
Wednesday, August 17, 2011 - 8:52am
tags:
patents, Viagra, Pfizer, drug reps, erectile dysfunction
Regeneron Says FDA Delays Eylea Drug for Blindness
Bloomberg
Wednesday, August 17, 2011 - 8:27am
tags:
Regeneron, FDA, blindness, Eylea, Lucentis, Roche

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.